Phase I trial of the targeted alpha-particle nano-generator actinium-225 (ac-225)-lintuzumab (anti-CD33; HuM195) in acute myeloid leukemia (AML) Meeting Abstract

  


Authors: Jurcic, J. G.; Rosenblat, T. L.; McDevitt, M. R.; Pandit-Taskar, N.; Carrasquillo, J. A.; Chanel, S. M.; Zikaras, K.; Frattini, M. G.; Maslak, P. G.; Cicic, D.; Larson, S. M.; Scheinberg, D. A.
Abstract Title: Phase I trial of the targeted alpha-particle nano-generator actinium-225 (ac-225)-lintuzumab (anti-CD33; HuM195) in acute myeloid leukemia (AML)
Meeting Title: 53rd Annual Meeting and Exposition of the American Society of Hematology (ASH)/Symposium on the Basic Science of Hemostasis and Thrombosis
Journal Title: Blood
Volume: 118
Issue: 21
Meeting Dates: 2011 Dec 10-13
Meeting Location: San Diego, CA
ISSN: 0006-4971
Publisher: American Society of Hematology  
Date Published: 2011-11-01
Start Page: 348
End Page: 349
Language: English
ACCESSION: WOS:000299597101039
PROVIDER: wos
DOI: 10.1182/blood.V118.21.768.768
Notes: --- - Meeting Abstract: 768 - 53rd Annual Meeting and Exposition of the American-Society-of-Hematology (ASH)/Symposium on the Basic Science of Hemostasis and Thrombosis - DEC 10-13, 2011 - San Diego, CA - "Source: Wos"
Altmetric
What is Altmetric?
Citation Impact
What is Dimensions Citation Badge?
BMJ Impact Analytics
MSK Authors
  1. Michael R Mcdevitt
    144 Mcdevitt
  2. Joseph G Jurcic
    134 Jurcic
  3. Mark Frattini
    45 Frattini
  4. Neeta Pandit-Taskar
    342 Pandit-Taskar
  5. Suzanne M Chanel
    31 Chanel
  6. David Scheinberg
    499 Scheinberg
  7. Jorge Carrasquillo
    140 Carrasquillo
  8. Todd Louis Rosenblat
    21 Rosenblat
  9. Peter Maslak
    197 Maslak
  10. Steven M Larson
    958 Larson
  11. Kevin Michael Zikaras
    1 Zikaras
Related MSK Work